ADC Therapeutics (ADCT) EPS (Basic): 2019-2023
Historic EPS (Basic) for ADC Therapeutics (ADCT) over the last 4 years, with Sep 2023 value amounting to -$0.57.
- ADC Therapeutics' EPS (Basic) fell 187.69% to -$0.57 in Q3 2023 from the same period last year, while for Sep 2023 it was -$0.43, marking a year-over-year decrease of 134.15%. This contributed to the annual value of -$0.00 for FY2022, which is 99.94% up from last year.
- According to the latest figures from Q3 2023, ADC Therapeutics' EPS (Basic) is -$0.57, which was up 5.00% from -$0.60 recorded in Q2 2023.
- ADC Therapeutics' 5-year EPS (Basic) high stood at $1.89 for Q2 2020, and its period low was -$0.60 during Q2 2023.
- In the last 3 years, ADC Therapeutics' EPS (Basic) had a median value of $0.65 in 2022 and averaged $0.31.
- Examining YoY changes over the last 5 years, ADC Therapeutics' EPS (Basic) showed a top increase of 236.36% in 2023 and a maximum decrease of 187.69% in 2023.
- ADC Therapeutics' EPS (Basic) (Quarterly) stood at -$0.00 in 2019, then reached $0.29 in 2020, then skyrocketed by 220.69% to -$0.45 in 2021, then skyrocketed by 99.93% to -$0.00 in 2022, then slumped by 187.69% to -$0.57 in 2023.
- Its last three reported values are -$0.57 in Q3 2023, -$0.60 for Q2 2023, and $0.74 during Q1 2023.